Latest news

Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony

Debiopharm reinforces the bond between Swiss and Japanese cancer research with the 2022 JCA-Mauvernay Award Ceremony

Debiopharm Encourages Breakthough Cancer Research In Japan Through its Competitive JCA Mauvernay Award

Debiopharm and the Japanese Cancer Association Announce Winners of the 2020 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Announce Winners of the 2019 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2018 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2017 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2016 JCA-Mauvernay Award